Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from 4DMedical Ltd ( (AU:4DX) ).
4DMedical Limited has announced that the University of Miami has adopted its CT:VQ™ technology for clinical use, marking the second U.S. academic medical center to do so after Stanford. This adoption is part of 4DMedical’s strategy to expand its presence in the U.S. market, supported by an introductory pricing period to encourage early clinical adoption. Additionally, 4DMedical has signed a two-year agreement with Lahey Hospital & Medical Center for the use of its IQ-UIP™ software, further solidifying its position in the respiratory imaging industry.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company specializing in advanced imaging and artificial intelligence for respiratory care. The company offers patented technology that transforms standard scans into detailed functional insights, aiding in the early detection, diagnosis, and monitoring of lung diseases. Their software portfolio includes FDA-cleared solutions like XV Lung Ventilation Analysis Software and CT:VQ™, which integrate seamlessly into hospital systems to enhance physician productivity and patient care.
Average Trading Volume: 5,817,382
Technical Sentiment Signal: Buy
Current Market Cap: A$980.5M
See more data about 4DX stock on TipRanks’ Stock Analysis page.